PDF herunterladen
CC BY 4.0 · Brazilian Journal of Oncology 2018; 14(50): 1-3
DOI: 10.5935/1806-6054.20190007
Editorial
Reviews Radiotherapy

Year in Review: The studies that changed the oncology practice in 2018: focus on radiation therapy

Bernardo P Salvajoli
1   Faculdade de Medicina da Universidade de São Paulo, Department of Radiology and Oncology, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP) - Sao Paulo - Saio Paulo - Brazil
2   Hospital do Coração (HCOR), Department of Radiation Oncology - Sao Paulo - Sao Paulo - Brazil
,
Clarissa C.A. Ramos
1   Faculdade de Medicina da Universidade de São Paulo, Department of Radiology and Oncology, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP) - Sao Paulo - Saio Paulo - Brazil
,
Flavia C.G. Gabrielli
1   Faculdade de Medicina da Universidade de São Paulo, Department of Radiology and Oncology, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP) - Sao Paulo - Saio Paulo - Brazil
3   Oncologia D'Or - Rede D'Or-São Luiz,, Department of Radiation Oncology - Sao Paulo - Sao Paulo - Brazil
,
Karina G. M. C. Vasconcelos
1   Faculdade de Medicina da Universidade de São Paulo, Department of Radiology and Oncology, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP) - Sao Paulo - Saio Paulo - Brazil
3   Oncologia D'Or - Rede D'Or-São Luiz,, Department of Radiation Oncology - Sao Paulo - Sao Paulo - Brazil
,
Fabio Y Moraes
4   General Hospital, Queen's University, Kingston, Department of Oncology - Division of Radiation Oncology - Kingston - ON - Canada
5   Princess Margaret Cancer Centre, University of Toronto, Department of Radiation Oncology - Radiation Medicine Program - Toronto - ON - Canada
,
Gustavo N Marta
1   Faculdade de Medicina da Universidade de São Paulo, Department of Radiology and Oncology, Division of Radiation Oncology, Instituto do Câncer do Estado de São Paulo (ICESP) - Sao Paulo - Saio Paulo - Brazil
6   Hospital Sírio-Libanês, Department of Radiation Oncology - Sao Paulo - Sao Paulo - Brazil
› Institutsangaben
Financial support: none to declare.
› Weitere Informationen
  Lizenzen und Reprints Alle Artikel dieser Rubrik

YEAR IN REVIEW: THE STUDIES THAT CHANGED THE ONCOLOGY PRACTICE IN 2018: FOCUS ON RADIATION THERAPY

The year of 2018 was a very important year for oncology. Numerous groundbreaking studies and novel approaches were published and or presented. For instance, the seminal work on the discovery of cancer therapy by inhibition of negative immune regulation was especially important and granted the 2018 Nobel Prize in Physiology or Medicine. Within the radiation therapy arena the importance of ablative treatment for oligometastatic patients has the ability to start a revolution on how we treat stage IV cancers([1]).

The current article aims to review the most relevant studies exploring radiation therapy (RT) as main intervention published or presented in 2018. We performed a configuring review aiming to unravel and understand the RT based changed practice published or presented articles. It is important to note that configuring reviews have the different purpose of aiming to find most important cases and so are not necessarily attempting to be exhaustive in their searching.



Publikationsverlauf

Eingereicht: 09. Dezember 2018

Angenommen: 17. Januar 2019

Artikel online veröffentlicht:
11. März 2025

© 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • REFERENCES

  • Palma DA, Olson RA, Harrow S, Gaede S, Louie AV, Haasbeek C. et al Stereotatic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR- COMET): results of randomized trial. Int J Rad Oncol Biol Phys 2018; 102 (3 Suppl): S3-S4
    Suche in Google Scholar
  • Yang H, Liu H, Chen Y, Zhu C, Fang W, Yu Z. et al AME Thoracic Surgery Collaborative Group. Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial. J Clin Oncol 2018; 36 (27) 2796-2803
    CrossrefPubMedSuche in Google Scholar
  • Yoon SM, Ryoo BY, Lee SJ, Kim JH, Shin JH, An JH. et al Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Randomized Clinical Trial. JAMA Oncol 2018; 4 (05) 661-669
    CrossrefPubMedSuche in Google Scholar
  • Pollack A, Karrison TG, Balogh Jr AG, Low D, Bruner DW, Wefel JS. et al Short Term Androgen Deprivation Therapy Without or With Pelvic Lymph Node Treatment Added to Prostate Bed Only Salvage Radiation Therapy: The NRG Oncology/RTOG 0534 SPPORT trial. Int J Rad Oncol Biol Phys 2018; 102 (05) 1605
    Suche in Google Scholar
  • Parker C.. Report from the ESMO 2018 presidential symposium-Radiotherapy to the primary tumour for men with newly diagnosed metastatic prostate cancer: survival results from STAMPEDE. ESMO Open 2018; 3 (06) e000451
    CrossrefPubMedSuche in Google Scholar
  • Widmark A, Gunnlaugsson A, Beckman L, Thellenberg-Karlsson C, Hoyer M, Lagerlund M. et al OC0599: Ultrahypofractionation for prostate cancer: Outcome from the Scandinavian phase 3 HYPO-RTPC trial. Radiother Oncol 2018; 127 (Suppl 1): S314
    Suche in Google Scholar
  • de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C. et al PORTEC study group. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol 2018; 19 (03) 295-309
    CrossrefPubMedSuche in Google Scholar
  • Wong JYC, Filippi AR, Dabaja BS, Yahalom J, Specht L.. Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys 2018; 101 (03) 521-529
    PubMedSuche in Google Scholar
  • Moeller B, Balagamwala EH, Chen A, Creach KM, Giaccone G, Koshy M. et al Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 Update of an American Society for Radiation Oncology (ASTRO) Evidence-Based Guideline. Pract Radiat Oncol 2018; 8 (04) 245-250
    CrossrefPubMedSuche in Google Scholar
  • Yap WK, Shih MC, Kuo C, Pai P, Chou WC, Chang KP. et al Development and Validation of a Nomogram for Assessing Survival in Patients With Metastatic Lung Cancer Referred for Radiotherapy for Bone Metastasis. JAMA Netw Open 2018; 1 (06) e183242
    PubMedSuche in Google Scholar
  • Bollen L, Jacobs WCH, Van der Linden YM, Van der Hel O, Taal W, Dijkstra PDS. A systematic review of prognostic factors predicting survival in patients with spinal bone metastases. Eur Spine J 2018; 27 (04) 799-805
    PubMedSuche in Google Scholar
  • Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM. et al Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Radiother Oncol 2018; 128 (02) 266-273
    PubMedSuche in Google Scholar